The signal across fields: cardiology is moving toward biology + behavior to prevent and treat disease earlier/better.
POLY-HF: A single once-daily polypill (β-blocker + MRA + SGLT2i) in HFrEF improved LVEF, QOL, and cut HF events by ~60% vs usual care → major signal that adherence-first...